Drug · DIN 02267233
TECTA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 21, 2013; first marketed March 15, 2006.
- Drug Identification Number (DIN)
- 02267233
- Company (DIN owner)
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Enteric-Coated)
- Route
- Oral
- Therapeutic class (ATC)
- Pantoprazole A02BC02
- Class
- Human
- Record last updated
- June 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PANTOPRAZOLE (PANTOPRAZOLE MAGNESIUM) | 40 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 13, 2016: NOC 18785Supplement to a New Drug Submission (SNDS) · Update to the labelling of the safety information with respect to interactionwith antiretroviral products
- December 21, 2012: NOC 13963New Drug Submission (NDS) · Manufacturer name change
- October 27, 2008: NOC 9860Supplement to a New Drug Submission (SNDS) · Product name change
- July 20, 2007: NOC 8926New Drug Submission (NDS) · Manufacturer name change
- April 22, 2005: NOC 6541New Drug Submission (NDS)